NVTA - Invitae Corp - SEC Form 4 Insider Trading Screener
23 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
| P | 4 | +6 | +8 | +12 | +0 |
| S | 6 | -3 | +1 | +3 | +0 |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2018-09-18 | NVTA | Dumond Patty | See Remarks | S - Sale | $16.58 | -645 | 98,811 | -1% | -$10,695 | |||||
2018-09-09 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $13.62 | -595 | 191,963 | 0% | -$8,104 | ||||||
2018-05-15 | NVTA | Guyer Shelly D | CFO | S - Sale | $6.96 | -5,135 | 39,865 | -11% | -$35,740 | ||||||
2018-05-15 | NVTA | George Sean E | Pres, CEO | S - Sale | $6.96 | -20,311 | 409,289 | -5% | -$141,365 | ||||||
2018-05-15 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $6.96 | -6,702 | 54,435 | -11% | -$46,646 | ||||||
2018-05-15 | NVTA | Bendekgey E Lee | COO | S - Sale | $6.96 | -6,388 | 52,396 | -11% | -$44,460 | ||||||
2018-05-15 | NVTA | Brida Thomas | GC | S - Sale | $6.96 | -1,979 | 25,973 | -7% | -$13,774 | ||||||
2018-05-15 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $6.96 | -6,012 | 52,558 | -10% | -$41,844 | ||||||
2018-05-15 | NVTA | Dumond Patty | See Remarks | S - Sale | $6.96 | -5,014 | 54,456 | -8% | -$34,897 | ||||||
2018-04-02 | NVTA | Scott Randal W | Exec COB | P - Purchase | $4.50 | +44,444 | 3,550,669 | +1% | +$199,998 | ||||||
2018-03-28 | NVTA | Baker Bros. Advisors LP | 10% | P - Purchase | $4.50 | +1,111,111 | 7,553,553 | +17% | +$5,000,000 | ||||||
| M | 2017-10-09 | NVTA | Dumond Patty | VP Fin., Principal Acct. Offic | S - Sale | $10.00 | -2,497 | 52,168 | -5% | -$24,970 | |||||
2017-09-12 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $9.40 | -612 | 58,570 | -1% | -$5,753 | ||||||
2017-02-16 | NVTA | Brida Thomas | GC | S - Sale | $9.69 | -766 | 24,720 | -3% | -$7,420 | +7 | +6 | +6 | |||
2017-02-15 | NVTA | Stueland Katherine | Chief Commercial Officer | S - Sale | $9.50 | -911 | 59,182 | -2% | -$8,655 | -5 | 0 | +2 | |||
2017-02-15 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $9.53 | -1,686 | 61,137 | -3% | -$16,068 | -5 | 0 | +2 | |||
2017-02-15 | NVTA | Dumond Patty | VP Fin., Principal Acct. Offic | S - Sale | $9.55 | -1,264 | 54,665 | -2% | -$12,068 | -5 | 0 | +2 | |||
2017-02-15 | NVTA | Brida Thomas | GC | S - Sale | $9.54 | -794 | 25,486 | -3% | -$7,573 | -5 | 0 | +2 | |||
2017-02-15 | NVTA | Bendekgey E Lee | CFO | S - Sale | $9.59 | -2,098 | 58,784 | -3% | -$20,120 | -5 | 0 | +2 | |||
2016-11-22 | NVTA | Scott Randal W | COB, CEO, 10% | P - Purchase | $6.00 | +66,666 | 3,506,225 | +2% | +$399,996 | +6 | 0 | +5 | |||
2016-11-18 | NVTA | Crouse Geoffrey | Dir | P - Purchase | $6.25 | +15,000 | 34,259 | +78% | +$93,750 | +2 | +6 | +11 | |||
2016-11-18 | NVTA | Aguiar Eric | Dir | P - Purchase | $6.28 | +10,000 | 10,000 | New | +$62,834 | +2 | +6 | +11 | |||
2016-11-17 | NVTA | Baker Bros. Advisors LP | 10% | P - Purchase | $6.00 | +733,333 | 6,554,039 | +13% | +$4,399,998 | +13 | +21 | +19 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |